We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Medical technology firm Danaher and software systems manufacturer Ventana are engaged in discussions on a possible joint acquisition of medical technology firm Vision Systems, the Australian Stock Exchange said Oct. 2.
Device firms that send manufacturing operations and clinical trials overseas may save time and money but will also need to exercise more vigilance over their suppliers, experts say.
A new licensing deal with a German diagnostic firm could see a cancer test developed by Dunedin-based Pacific Edge Biotechnology
hit a market worth millions in a year.
Xenomics, Inc., the source of next-generation medical DNA diagnostic tests, announced that it has developed a proprietary test for the detection of NPM gene mutations, a recently discovered genetic marker for Acute Myeloid Leukemia (AML).
Researchers at the Technion-Israel Institute of Technology are proposing a revolutionary approach to prevent the common post-balloon angioplasty problem of restenosis (re-clogging of coronary
arteries).
Implanting a Cordis Corp. stent in Herbert Entenberg's body might have saved his life, but it also made his life a living hell, says
a Boynton Beach retiree who has filed a lawsuit against the company.